期刊文献+

早发性帕金森病患者的临床特征 被引量:1

Clinical features of patients with early-onset Parkinson's disease
下载PDF
导出
摘要 目的:探讨早发性帕金森病的临床特征。方法:对76例早发性帕金森病患者的临床资料进行回顾性分析。结果:76例患者中15例有家族史,11例呈常染色体隐性遗传(autosomalrecessiveParkinson'sdisease,ARPD),4例呈常染色体显性遗传(autosomaldominartParkinson'sdisease,ADPD);症状轻,病程长,症状常左右不对称,腱反射活跃和症状波动较常见,头部CT或MRI检查一般正常,对多巴制剂反应良好,但其所诱发的副作用出现早。与散发性患者相比,ARPD患者发病年龄更早(26.9±9.43)岁,病程更长(8.72±5.09)年;而病情较轻,症状波动和腱反射活跃更多见,多巴制剂副作用更常见。结论:早发性帕金森病可能是一个独立的疾病实体。ARPD与散发性早发性PD临床特征不同,提示两者可能具有不同的发病机制。 AIM:To explore the clinical features of patients with early-onset Parkinson's disease(EOPD). METHODS:General status,clinical manifestation and laboratory findings of 76 pa tients with EOPD were reviewed. RESULTS:Among the 76 patients with EOPD,15 patients had family history,includi ng 11 cases of autosomal recessive Parkinson's disease(ARPD) and 4 of autosomal dominant Parkinson's disease(ADPD).Analysis of the clinical features showed the symptoms of PD were mild and unsymmetric.The disease progression was slowly.Hype rreflexia and diural fluctuation were often seen in patients, but brain CT and M RI were often normal.Response to levodopa was satisfactory,but dopa-induced sid e effects occurred early. Compared with sporadic PD,ARPD tended to have earlier age at onset[(26.9±9.43) years old], milder symptoms of PD,longer duration of p rogression[(8.72±5.09) years],more frequent presence of hyperreglexia and diura l fluctuation, and more frequent appearance of dopa-related side effects. CONCLUSION:EOPD may be an independent disease entity.ARPD is different from sp oradic EOPD,which suggests that there may be different pathogenesis between thes e two subtypes.
出处 《中国临床康复》 CSCD 2004年第13期2432-2434,共3页 Chinese Journal of Clinical Rehabilitation
基金 国家863高技术研究发展计划资助项目(2002BA711A07) 国家自然科学基金(30370515) 高等学校博士学科点专项科研基金(20020533024) 湖南省自然科学基金(02JJY2042)~~
  • 相关文献

参考文献14

  • 1Kitada T,Asakawa S,Hattori N,et al.Mutations in the parkin gene cause autosomal recessive juvenile Parkinsonism.Nature 1998; 392(6676):605-8
  • 2Lucking CB,Durr A,Bonifati V,et al.Association between early-onset Parkinson's disease and mutations in the parkin gene.N Engl J Med 2000; 342:1560-7
  • 3Tanner CM,Ottman R,Goldman SM,et al.Parkinson disease in twins:an etiologic study.JAMA 1999; 281(4):341-6
  • 4Payami H,Zareparsi S,James D,et al.Familial aggregation of Parkinson disease:a comparative study of early-onset and late-onset disease.Arch Neurol 2002; 59:848-50
  • 5Ishikawa A,Tsuji S.Clinical analysis of 17 patients in 12 Japanese families with autosomal-recessive type juvenile parkinsonism.Neurology 1996; 47:160-6
  • 6Gasser T.Genetics of Parkinson's disease.J Neurol 2001; 248:833-40
  • 7Dawson TM,Dawson VL.Rare genetic mutations shed light on the pathogenesis of Parkinson disease.J Clin Invest 2003; 111(2):145-51
  • 8Spillantini MG,Schmidt ML,Lee VM,et al.Alpha-synuclein in Lewy bodies.Nature 1997; 388(6645):839-40
  • 9Lowe J,McDermott H,Landon M,et al.Ubiquitin carboxyl-terminal hydroiase(PGP 9.5)is selectively present in uhiquitianted inclusion bodies characteristic of human neurodegenerative diseases.J Pathol 1990; 161(2):153-60
  • 10Feany MB,Pallanek LJ.Parkin:a multipurpose neuroprotective agent? Neuron 2003; 38(1):13-6

二级参考文献16

  • 1[1]Joseph J. Levodopa strengths and weaknesses. Neurology 2002; 58(4 Suppl 1):19 -32
  • 2[2]Ball J. Current advances in Parkinson's disease. Trends Neuronsci 2001; 24(7):367 - 9
  • 3[3]Douglas C, Wallace. Mouse Models for Mitochondrial Disesse. Semin Med Genet 2001; 106:71-93
  • 4[4]Beal MF. Energetics in the pathogenesis of neurodegenerative diseases . Trends in Neuroscience 2000; 23:298 - 304
  • 5[5]Birgit L, Jochen R. Molecular physiology of neuronal K-ATP channels(Review) .Molecular Membrane Biology 2001; 18:117-27
  • 6[6]Paik SR, Shin HJ, Lee JH. Metal-catalyzed oxidation of alpha-synuclein in the presence of copper ( Ⅱ ) and hydrogen peroxide . Arch Biochem Biophys 2000;378:269 - 77
  • 7[7]Blandini, Nappi G, Tassorelli C, Martignoni E. Functional change of the basal ganglia circuity in Parkinsnn' s disease. Prog Neurobiol 2000; 62 ( 1 ): 63 - 88
  • 8[8]David B, Sakina T, Nathalie L, et al. Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease. Prog Neurobiol 2001; 65:135 -72
  • 9[9]Vilab M, Jackson-Lewis V, Guegan C, et al. The role of glial cells in Parkinson' s disease. Curr opin Neurol 2001; 14(4):483 -9
  • 10[10]Clayton PT, Smith I, Harding B, et al. Subacute combined degeneration of the cord, dementia and parkinsonism due to an inborn error of folate metabolism. J Neurosury Psychiatry 1986; 49:920-7

共引文献26

同被引文献16

  • 1Marras C, Rochon P, Lang AE. Predicting motor decline and disability in Parkinson disease: a systematic review. Arch Neurol 2002; 59 (11 ): 1724 -8
  • 2Poewe WH, Wenning GK. The natural history of Parkinson's disease. Ann Neurol 1998;44(3 Suppl 1): S1 -9
  • 3Marder K, Levy G, Louis ED, et al. Familial aggregation of early- and late-onset Parkinson's disease. Ann Neurol 2003; 54 (4): 507 - 13
  • 4Hedrich K, Marder K, Harris J, et al. Evaluation of 50 probands with early-onset Parkinson's disease for Parkin mutations. Neurology 2002; 58 (8): 1239 -46
  • 5De La Fuente-Fernandez R, Lim AS, et al. Age and severity of nigrostriatal damage at onset of Parkinson's disease. Synapse 2003; 47 (2): 152 - 8.
  • 6Diederich NJ, Moore CG, Leurgans SE, et al. Parkinson disease with old-age onset: a comparative study with subjects with middle-age onset. Arch Neurol 2003;60(4): 529 -33
  • 7Cookson MR. Pathways to Parkinsonism. Neuron 2003; 37 ( 1 ): 7 - 10
  • 8Valente EM, Abou-Sleiman PM, Caputo V, et al. Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 2004; 304 (5674): 1158 -60
  • 9Lucking CB, Durr A, Bonifati V, et al. Association between early-onset Parkinson's disease and mutations in the parkin gene. French Parkinson's Disease Genetics Study Group. N Engl J Med 2000; 342(21 ): 1560 - 7
  • 10Hely MA, Morris JG, Traficante R, et al. The sydney multicentre study of Parkinson's disease: progression and mortality at 10 years. J Neurol Neurosurg Psychiatry 1999;67(3): 300 -7

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部